Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating sorafenib tosylate in patients with hepatocellular carcinoma that can be removed by surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Liver Cancer | Phase 2 | Status: UNKNOWN